Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Smith

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Obesity Research|May 28, 2005
Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivityXiaolin Yang, Per-Anders Jansson, Fredrik Pellmé, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Acute hyperinsulinemia differentially regulates interstitial and circulating adiponectin oligomeric pattern in lean and insulin-resistant, obese individualsGiuseppe Murdolo, Ann Hammarstedt, Martin Schmelz, et al.
Diabetes/Metabolism Research and Reviews|August 30, 2008
Inflamed adipose tissue, insulin resistance and vascular injuryChristian X Andersson, Birgit Gustafson, Ann Hammarstedt, et al.
Diabetes Care|April 17, 2020
Microbiota-Related Metabolites and the Risk of Type 2 DiabetesJagadish Vangipurapu, Lilian Fernandes Silva, Teemu Kuulasmaa, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 23, 2009
Inflammation and impaired adipogenesis in hypertrophic obesity in manBirgit Gustafson, Silvia Gogg, Shahram Hedjazifar, et al.
Obesity (Silver Spring, Md.)|January 14, 2012
The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patientsJian Yang, Bjorn Eliasson, Ulf Smith, et al.
Obesity Research|April 12, 2003
Predictors of weight loss in adults with topiramate-treated epilepsyElinor Ben-Menachem, Mette Axelsen, Else Hellebö Johanson, et al.
Molecular and Cellular Endocrinology|July 1, 2014
Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintainedEmmelie Cansby, Annika Nerstedt, Manoj Amrutkar, et al.
Journal of Cell Communication and Signaling|December 17, 2017
CCN5/WISP2 and metabolic diseasesJohn R Grünberg, Johannes Elvin, Alexandra Paul, et al.
Adipocyte|August 29, 2015
Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patientsBjorn Eliasson, Ulf Smith, Shawn Mullen, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Obesity Research|May 28, 2005
Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivityXiaolin Yang, Per-Anders Jansson, Fredrik Pellmé, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Acute hyperinsulinemia differentially regulates interstitial and circulating adiponectin oligomeric pattern in lean and insulin-resistant, obese individualsGiuseppe Murdolo, Ann Hammarstedt, Martin Schmelz, et al.
Diabetes/Metabolism Research and Reviews|August 30, 2008
Inflamed adipose tissue, insulin resistance and vascular injuryChristian X Andersson, Birgit Gustafson, Ann Hammarstedt, et al.
Diabetes Care|April 17, 2020
Microbiota-Related Metabolites and the Risk of Type 2 DiabetesJagadish Vangipurapu, Lilian Fernandes Silva, Teemu Kuulasmaa, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 23, 2009
Inflammation and impaired adipogenesis in hypertrophic obesity in manBirgit Gustafson, Silvia Gogg, Shahram Hedjazifar, et al.
Obesity (Silver Spring, Md.)|January 14, 2012
The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patientsJian Yang, Bjorn Eliasson, Ulf Smith, et al.
Obesity Research|April 12, 2003
Predictors of weight loss in adults with topiramate-treated epilepsyElinor Ben-Menachem, Mette Axelsen, Else Hellebö Johanson, et al.
Molecular and Cellular Endocrinology|July 1, 2014
Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintainedEmmelie Cansby, Annika Nerstedt, Manoj Amrutkar, et al.
Journal of Cell Communication and Signaling|December 17, 2017
CCN5/WISP2 and metabolic diseasesJohn R Grünberg, Johannes Elvin, Alexandra Paul, et al.
Adipocyte|August 29, 2015
Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patientsBjorn Eliasson, Ulf Smith, Shawn Mullen, et al.
Pageof 13